Effect on Off-Label Marketing in the 2010 Budget Details?
The Department of Health and Human Services recently released its budget proposal for 2010. As it relates to the FDA, HHS is looking to build…
Read More »Pharma 101 – Pharmaceutical Fraud
Pharmaceutical Fraud News & Insight form the Qui Tam and False Claims Act Perspective
Contact FormTag Archives: Off-label use
Purdue Pharma Agrees to $19.5 Million Settlement Over Off Label Marketing of OxyContin
Purdue Pharma has agreed to settle claims by 26 states and the District of Columbia for marketing and promoting OxyContin for unapproved uses i.e. for…
Read More »Eli Lilly and Company in More Hot Water
Montana is the latest state to sue Eli Lilly and Company, alleging that the company improperly and fraudulently marketed Zyprexa, an antipsychotic drug for unapproved…
Read More »InterMune Pays Nearly $37 Million to Settle Claims for Off Label Marketing
InterMune Inc., a Brisbane, California, biopharmaceutical company, has agreed to pay the government $36.9 million to resolve criminal charges and civil liabilities in connection with…
Read More »$30 Million Off-Label Case
The State of Mississipi has filed a sweeping lawsuit against the pharmaceutical company Eli Lilly (see www.lilly.com) alleging the pharmaceutical compay illegally marketed Zyprexa (an…
Read More »